News

Welcome back Mette Bach Dyremose

Nov 5, 2024

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion’s communication efforts!

With over 20 years of experience in strategic communication, business development, and life sciences, Mette has a unique talent for turning complex scientific insights into compelling, impactful messages. She began her journey with Ferring Pharmaceuticals, where she developed her expertise in event management and translating research into meaningful narratives.

In her previous role with ReproUnion and Medicon Valley Alliance, Mette was instrumental in shaping the ReproUnion brand and building awareness around key initiatives within reproductive health, including the successful launch of RUBIC. Recently, she contributed to the HALRIC Hanseatic Life Science Research Infrastructure Consortium project, establishing its communication strategy and driving engagement across academia, hospitals, and industry.

With her deep insights and strategic vision, Mette’s return marks an exciting new chapter for ReproUnion as we continue to build an innovative reproductive health platform bridging science, technology, and clinical practice. Alongside ReproUnion, Mette will also work with DiaUnion, supporting their communication and public affairs initiatives.

Welcome back, Mette! We look forward to all that’s ahead with you on the team!

MORE NEWS


PhD students complete the SmiLe e-Campus Innovation Course

Between April and June, nine ReproUnion-affiliated young researchers and doctors participated the 12-week online e-Campus Innovation Course, a programme developed in collaboration with SmiLe Venture Hub. The course is designed to support early-stage scientists in...

read more

ReproTalk #2: Full House and fresh insights on infertility

This second event organized by ReproYoung on 22 May once again filled the auditorium with an incredibly engaged audience at Medicon Valley Alliance in Copenhagen. The topic was male and female infertility – assessment and prognostic factors - featuring two insightful...

read more